Product Program year 2021 Source: CMS Open Payments

General Ep

Device Therapies

Open in the dashboard

General payments

$525,876

307 payments

Research payments

$0

0 payments

Through program year 2021, $525,876 in general payments and $0 in research payments were reported against General Ep (Therapies).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2021 General $435,506 39
2020 General $129 3
2019 General $90,241 265

Breakdown

Who paid General payments · program years 2019–2021
  1. Boston Scientific Corporation $525,876 307 payments
Top recipients General payments · program year 2021
  1. Hugh McElderry Clinical Cardiac Electrophysiology · Birmingham, AL $257,317 59% · 1 payment
  2. Christian Eversull Internal Medicine · Stanford, CA $67,210 15% · 1 payment
  3. Darby McElderry Pediatrics · Birmingham, AL $53,746 12% · 1 payment
  4. Roger Winkle Clinical Cardiac Electrophysiology · E Palo Alto, CA $38,309 9% · 1 payment
  5. William Stevenson Clinical Cardiac Electrophysiology · Nashville, TN $5,130 1% · 1 payment

The top 5 of 37 recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Clinical Cardiac Electrophysiology Internal Medicine $309,168 71% · 25 practitioners
  2. Internal Medicine $67,210 16% · 1 practitioner
  3. Pediatrics $53,746 12% · 1 practitioner
  4. Cardiovascular Disease Internal Medicine $3,291 <1% · 5 practitioners
  5. Interventional Cardiology Internal Medicine $45 <1% · 1 practitioner

The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. Alabama $311,063 71% · 2 recipients
  2. California $105,928 24% · 8 recipients
  3. Tennessee $5,130 1% · 1 recipient
  4. Ohio $4,791 1% · 6 recipients
  5. Minnesota $3,954 <1% · 1 recipient

The top 5 of 13 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

307 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record